SAVA Net Margin

The Net Margin of Cassava Sciences Inc (SAVA) is 76.70%.

Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

SAVA Net Margin - Historical Value

Date	Value
2024-12-31	76.70%

SAVA Net Margin - Peers Comparison

Ticker	Name	Value
FULC	Fulcrum Therapeutics Inc	-12.16%
OCUL	Ocular Therapeutix Inc	-303.67%
RPRX	Royalty Pharma PLC	37.95%
ZTS	Zoetis Inc	26.86%
CBAY	CymaBay Therapeutics Inc	-339.10%
EOLS	Evolus Inc	-18.94%
RLMD	Relmada Therapeutics Inc	-500.00%
PRTK	Paratek Pharmaceuticals Inc	-39.66%
RDHL	Redhill Biopharma Ltd	366.25%
RVNC	Revance Therapeutics Inc	-138.43%
CTLT	Catalent Inc	-23.81%
ITCI	Intra-Cellular Therapies Inc	-10.97%
KLDO	Kaleido Biosciences Inc	-8178.26%
LLY	Eli Lilly and Co	23.51%
MRK	Merck & Co Inc	26.68%
TARS	Tarsus Pharmaceuticals Inc	-63.16%
ACRS	Aclaris Therapeutics Inc	-705.48%
BMY	Bristol-Myers Squibb Co	-18.53%
CARA	Cara Therapeutics Inc	-992.95%
DRRX	DURECT Corp	-409.85%
PHAT	Phathom Pharmaceuticals Inc	-605.09%
AMPE	Ampio Pharmaceuticals Inc	-48020.00%
EYPT	EyePoint Pharmaceuticals Inc	-302.43%
WVE	WAVE Life Sciences Ltd	-89.57%
ELAN	Elanco Animal Health Inc	7.61%
OMER	Omeros Corp	-187.13%
VTRS	Viatris Inc	-4.30%
ZOM	Zomedica Corp	-137.10%
AXSM	Axsome Therapeutics Inc	-74.47%
JNJ	Johnson & Johnson	15.84%
SEEL	Seelos Therapeutics Inc	-1719.56%
TFFP	TFF Pharmaceuticals Inc	-2894.69%
VYNE	Vyne Therapeutics Inc	-7950.90%
PFE	Pfizer Inc	12.62%